Fairchem Organics Limited

NSE:FAIRCHEMOR.NS

849.1 (INR) • At close May 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q3
Revenue 1,135.7081,386.1861,649.2831,515.081,476.5341,518.7771,603.4951,515.0771,022.2911,682.5852,249.4171,773.6981,582.7191,676.6171,389.7641,590.9351,068.293948.555350.118891.636801.359
Cost of Revenue 855.0371,052.2631,359.9071,159.061,069.8511,139.0211,267.6771,104.084815.5151,362.8431,624.7021,436.481,154.4281,155.889900.4091,166.86716.507597.612244.683603.691550.16
Gross Profit 280.671333.923289.376356.02406.683379.756335.818410.993206.776319.742624.715337.218428.291520.728489.355424.075351.786350.943105.435287.945251.199
Gross Profit Ratio 0.2470.2410.1750.2350.2750.250.2090.2710.2020.190.2780.190.2710.3110.3520.2670.3290.370.3010.3230.313
Reseach & Development Expenses 0001.6260001.9480001.9390001.539000.4222.5980
General & Administrative Expenses 000174.55200072.21100043.57800067.393004.08234.6190
Selling & Marketing Expenses 0002.4280002.5970003.5350001.948006.9141.1520
SG&A 0097.456176.9871.77378.05551.64174.80860.6173.20248.65547.11345.06644.21455.14769.34137.9848.93110.99635.77134.89
Other Expenses 229.043333.92302.8132.4524.5511.5231.6882.7190.0332.837-2.840.9130.3654.058-0.1690.0730.1070.006-63.7491.366
Operating Expenses 229.043333.92397.456184.51233.157233.121241.075239.923190.891247.135243.005167.704233.271220.678177.737164.967155.729213.25294.26197.612148.93
Operating Income 51.62861.148191.92171.51175.978151.18694.743359.57318.60472.64381.71169.514195.02300.05311.618277.01196.057137.79813.639211.35102.269
Operating Income Ratio 0.0450.0440.1160.1130.1190.10.0590.2370.0180.0430.170.0960.1230.1790.2240.1740.1840.1450.0390.2370.128
Total Other Income Expenses Net -4.468-6.393-5.754-3.361-7.208-8.482-12.003-199.995-6.5-16.134-21.221-17.249-14.397-19.864-12.288-18.97-16.014-15.516-14.857-23.34-15.733
Income Before Tax 47.1654.755186.166159.58166.318138.15382.74159.5789.38556.473360.489152.265180.623280.186299.33240.138180.043122.175-3.683166.99386.536
Income Before Tax Ratio 0.0420.040.1130.1050.1130.0910.0520.1050.0090.0340.160.0860.1140.1670.2150.1510.1690.129-0.0110.1870.108
Income Tax Expense 11.98214.64947.64440.9743.0135.29721.51440.9743.29916.44390.19439.83346.08571.21276.2151.83946.01331.6-1.78536.26621.216
Net Income 35.17840.106138.522117.613123.308102.85661.226118.6046.08640.03270.295112.432134.538208.974223.12188.299134.0390.575-1.898130.72765.32
Net Income Ratio 0.0310.0290.0840.0780.0840.0680.0380.0780.0060.0240.120.0630.0850.1250.1610.1180.1250.095-0.0050.1470.082
EPS 2.73.0810.649.119.477.94.79.110.473.0720.768.6310.3316.0517.1414.4610.296.96-0.1510.075.03
EPS Diluted 2.73.0810.649.119.477.94.79.110.473.0720.768.6310.3316.0517.1414.4610.296.96-0.1510.075.03
EBITDA 83.08791.351220.145187.611199.961172.944117.808194.03439.46693.142403.426187.485214.096318.06332.628277.865212.755160.00127.433200.933119.684
EBITDA Ratio 0.0730.0660.1330.1240.1350.1140.0730.1280.0390.0550.1790.1060.1350.190.2390.1750.1990.1690.0780.2250.149